Intellipharmaceutics International Inc
Change company Symbol lookup
Select an option...
IPCI Intellipharmaceutics International Inc
$RDM.EU FT DJ SL MIC EU
ABQQ Ab International Group Corp
ABLT American Biltrite Inc
ABIO ARCA Biopharma Inc
ABG Asbury Automotive Group Inc
ABEO Abeona Therapeutics Inc
ABDC Alcentra Capital Corp
ABCB Ameris Bancorp
ABBY Abby Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Value
Based in CanadaCompany profile

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

Closing Price
$0.34
Day's Change
0.0132 (4.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.35
Day's Low
0.319
Volume
(Below Average)
Volume:
1,161,814

10-day average volume:
1,431,447
1,161,814
  • Prev Close
    0.3268
  • Today's Open
    0.3465
  • Day's Range
    0.319-0.35
  • Avg Vol (10-day)
    1.4M
  • Last (time)
    3:59p ET 02/15/19
  • Last (size)
    500
  • 52-Wk Range
    0.2001 - 7.60
    LowHigh
  • (02/16/18 - 12/13/18)
    69.92%
  • 126.6%
  • Market Cap
    6.6M
  • Shares Outstanding
    19.5M
  • -3.26
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.2
  • 10.91
  • (% of float 01/31/19)
    1.12

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.